T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.37B |
| 2 |
Intel
INTC
|
+$1.28B |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1B |
| 4 |
Nike
NKE
|
+$859M |
| 5 |
Uber
UBER
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.67B |
| 2 |
Amazon
AMZN
|
+$2.15B |
| 3 |
NVIDIA
NVDA
|
+$1.64B |
| 4 |
Humana
HUM
|
+$1.57B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.09% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Green Brick Partners
GRBK
$3.04B
| $24.9M | ﹤0.01% |
479,109
+246,310
| +106% | +$11.2M |
|
902
Immuneering
IMRX
$336M
| $24.8M | ﹤0.01% |
3,378,100
-155,222
| -4% | -$1.03M |
|
903
Prestige Consumer Healthcare
PBH
$2.43B
| $24.8M | ﹤0.01% |
405,289
-2,014
| -0.5% | -$120K |
|
904
Marathon Digital Holdings
MARA
$3.56B
| $24.8M | ﹤0.01% |
1,055,242
+988,766
| +1,487% | +$12.5M |
|
905
SM Energy
SM
$7.71B
| $24.8M | ﹤0.01% |
639,668
+9,361
| +1% | +$361K |
|
906
Nurix Therapeutics
NRIX
$2.82B
| $24.7M | ﹤0.01% |
2,389,966
+11,988
| +0.5% | +$82.2K |
|
907
Immatics
IMTX
$1.31B
| $24.6M | ﹤0.01% |
2,334,169
+719,634
| +45% | +$6.62M |
|
908
Paycom
PAYC
$10.1B
| $24.5M | ﹤0.01% |
118,489
-46,775
| -28% | -$9.89M |
|
909
Expeditors International
EXPD
$24.3B
| $24.5M | ﹤0.01% |
192,448
-120,576
| -39% | -$14.2M |
|
910
Trex
TREX
$5.1B
| $24.4M | ﹤0.01% |
294,779
+12,990
| +5% | +$862K |
|
911
Everest Group
EG
$14B
| $24.2M | ﹤0.01% |
68,563
+1,561
| +2% | +$605K |
|
|
NARI
912
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $24.1M | ﹤0.01% |
371,344
-878,550
| -70% | -$52.9M |
|
913
Payoneer
PAYO
$2.42B
| $24M | ﹤0.01% |
4,611,558
+404,237
| +10% | +$2.23M |
|
914
Principal Financial Group
PFG
$24.6B
| $24M | ﹤0.01% |
304,450
+5,718
| +2% | +$414K |
|
915
Dell
DELL
$320B
| $23.8M | ﹤0.01% |
310,858
+205,926
| +196% | +$14.6M |
|
916
Pharvaris
PHVS
$2.38B
| $23.6M | ﹤0.01% |
+842,698
| New | +$17.1M |
|
917
B2Gold
BTG
$6.7B
| $23.6M | ﹤0.01% |
+7,474,972
| New | +$23.6M |
|
918
Leidos
LDOS
$17.9B
| $23.5M | ﹤0.01% |
217,012
+3,385
| +2% | +$345K |
|
919
iShares Core S&P 500 ETF
IVV
$910B
| $23.4M | ﹤0.01% |
48,949
+6,843
| +16% | +$3.06M |
|
920
Albemarle
ALB
$15.4B
| $23.1M | ﹤0.01% |
160,077
-35,424
| -18% | -$4.86M |
|
921
Globe Life
GL
$14B
| $23.1M | ﹤0.01% |
189,448
+1,834
| +1% | +$216K |
|
922
Royal Gold
RGLD
$19.1B
| $22.7M | ﹤0.01% |
187,734
-55,395
| -23% | -$6.26M |
|
923
SentinelOne
S
$8.17B
| $22.5M | ﹤0.01% |
819,572
+607,449
| +286% | +$11.8M |
|
924
Schrodinger
SDGR
$1.38B
| $22.5M | ﹤0.01% |
628,179
-88,285
| -12% | -$2.56M |
|
925
Wolfspeed
WOLF
$1.64B
| $22.4M | ﹤0.01% |
515,337
+454,252
| +744% | +$16.5M |
|
Similar funds
T. Rowe Price Associates's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
- T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
- T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
- T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
- T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
- T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.
Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.